Edwards Lifesciences Co. (NYSE:EW – Free Report) – Investment analysts at Leerink Partnrs lifted their FY2024 earnings per ...

Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $73.71, a high estimate of ...

Leerink Partners analyst Mike Kratky maintained a Hold rating on Edwards Lifesciences (EW – Research Report) on November 25 and set a price ...

Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

Edwards Lifesciences' estimated fair value is US$69.12 based on 2 Stage Free Cash Flow to Equity Edwards Lifesciences' US$71.27 share price indicates it is trading at similar levels as its fair value ...

Eagle Asset Management Inc. grew its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 38.0% during ...

RBC Capital raised the firm’s price target on Edwards Lifesciences (EW) to $80 from $75 and keeps an Outperform rating on the shares. The firm ...

EW LEGAL UPDATE: A Lawsuit Has Been Filed Against Edwards Lifesciences For Securities Fraud - Contact BFA Law Before Court Deadline (NYSE:EW) ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

On Monday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $71.27 which represents a slight increase of $0.79 or 1.12% from the prior close of $70.48. The stock opened at ...

EW STOCK REPORT: Suffer Losses On Your Edwards Lifesciences Investment? Contact BFA Law About The Pending Class Action Lawsuit (NYSE:EW) ...